vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and N-able, Inc. (NABL). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $130.3M, roughly 1.4× N-able, Inc.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 11.8%). N-able, Inc. produced more free cash flow last quarter ($20.9M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 7.0%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.
FOLD vs NABL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $130.3M |
| Net Profit | $1.7M | — |
| Gross Margin | 85.7% | 76.2% |
| Operating Margin | 8.6% | 10.2% |
| Net Margin | 0.9% | — |
| Revenue YoY | 23.7% | 11.8% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $130.3M | ||
| Q3 25 | $169.1M | $131.7M | ||
| Q2 25 | $154.7M | $131.2M | ||
| Q1 25 | $125.2M | $118.2M | ||
| Q4 24 | $149.7M | $116.5M | ||
| Q3 24 | $141.5M | $116.4M | ||
| Q2 24 | $126.7M | $119.4M | ||
| Q1 24 | $110.4M | $113.7M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $17.3M | $1.4M | ||
| Q2 25 | $-24.4M | $-4.0M | ||
| Q1 25 | $-21.7M | $-7.2M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $-6.7M | $10.8M | ||
| Q2 24 | $-15.7M | $9.5M | ||
| Q1 24 | $-48.4M | $7.5M |
| Q4 25 | 85.7% | 76.2% | ||
| Q3 25 | 88.5% | 77.5% | ||
| Q2 25 | 90.2% | 78.1% | ||
| Q1 25 | 90.7% | 76.6% | ||
| Q4 24 | 90.1% | 80.0% | ||
| Q3 24 | 90.6% | 82.9% | ||
| Q2 24 | 91.1% | 84.0% | ||
| Q1 24 | 87.7% | 83.9% |
| Q4 25 | 8.6% | 10.2% | ||
| Q3 25 | 20.3% | 8.8% | ||
| Q2 25 | -6.1% | 7.7% | ||
| Q1 25 | -6.3% | 1.5% | ||
| Q4 24 | 10.7% | 13.7% | ||
| Q3 24 | 15.3% | 20.5% | ||
| Q2 24 | 11.8% | 18.4% | ||
| Q1 24 | -25.1% | 18.0% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 10.2% | 1.1% | ||
| Q2 25 | -15.8% | -3.1% | ||
| Q1 25 | -17.3% | -6.1% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | -4.8% | 9.2% | ||
| Q2 24 | -12.4% | 7.9% | ||
| Q1 24 | -43.9% | 6.6% |
| Q4 25 | $0.00 | $-0.04 | ||
| Q3 25 | $0.06 | $0.01 | ||
| Q2 25 | $-0.08 | $-0.02 | ||
| Q1 25 | $-0.07 | $-0.04 | ||
| Q4 24 | $0.05 | $0.01 | ||
| Q3 24 | $-0.02 | $0.06 | ||
| Q2 24 | $-0.05 | $0.05 | ||
| Q1 24 | $-0.16 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $111.8M |
| Total DebtLower is stronger | $392.7M | $393.9M |
| Stockholders' EquityBook value | $274.2M | $804.7M |
| Total Assets | $949.9M | $1.4B |
| Debt / EquityLower = less leverage | 1.43× | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $111.8M | ||
| Q3 25 | $263.8M | $101.4M | ||
| Q2 25 | $231.0M | $93.9M | ||
| Q1 25 | $250.6M | $94.1M | ||
| Q4 24 | $249.9M | $85.2M | ||
| Q3 24 | $249.8M | $174.4M | ||
| Q2 24 | $260.1M | $157.5M | ||
| Q1 24 | $239.6M | $139.2M |
| Q4 25 | $392.7M | $393.9M | ||
| Q3 25 | $392.0M | $331.7M | ||
| Q2 25 | $391.3M | $332.1M | ||
| Q1 25 | $390.7M | $332.6M | ||
| Q4 24 | $390.1M | $333.1M | ||
| Q3 24 | $389.5M | $333.6M | ||
| Q2 24 | $388.9M | $334.1M | ||
| Q1 24 | $388.4M | $334.5M |
| Q4 25 | $274.2M | $804.7M | ||
| Q3 25 | $230.4M | $813.4M | ||
| Q2 25 | $204.3M | $809.4M | ||
| Q1 25 | $193.6M | $775.1M | ||
| Q4 24 | $194.0M | $759.3M | ||
| Q3 24 | $178.8M | $765.0M | ||
| Q2 24 | $132.5M | $724.4M | ||
| Q1 24 | $130.7M | $709.1M |
| Q4 25 | $949.9M | $1.4B | ||
| Q3 25 | $868.8M | $1.4B | ||
| Q2 25 | $815.3M | $1.4B | ||
| Q1 25 | $789.8M | $1.4B | ||
| Q4 24 | $785.0M | $1.3B | ||
| Q3 24 | $786.6M | $1.2B | ||
| Q2 24 | $749.5M | $1.2B | ||
| Q1 24 | $721.8M | $1.1B |
| Q4 25 | 1.43× | 0.49× | ||
| Q3 25 | 1.70× | 0.41× | ||
| Q2 25 | 1.92× | 0.41× | ||
| Q1 25 | 2.02× | 0.43× | ||
| Q4 24 | 2.01× | 0.44× | ||
| Q3 24 | 2.18× | 0.44× | ||
| Q2 24 | 2.93× | 0.46× | ||
| Q1 24 | 2.97× | 0.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $25.3M |
| Free Cash FlowOCF − Capex | $16.0M | $20.9M |
| FCF MarginFCF / Revenue | 8.6% | 16.0% |
| Capex IntensityCapex / Revenue | 0.2% | 3.4% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $75.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $25.3M | ||
| Q3 25 | $35.7M | $24.0M | ||
| Q2 25 | $-26.5M | $24.2M | ||
| Q1 25 | $7.8M | $19.7M | ||
| Q4 24 | $-3.9M | $26.0M | ||
| Q3 24 | $-23.0M | $22.0M | ||
| Q2 24 | $22.7M | $27.3M | ||
| Q1 24 | $-29.7M | $4.2M |
| Q4 25 | $16.0M | $20.9M | ||
| Q3 25 | $35.3M | $17.4M | ||
| Q2 25 | $-28.9M | $20.4M | ||
| Q1 25 | $7.5M | $16.4M | ||
| Q4 24 | $-4.2M | $18.8M | ||
| Q3 24 | $-23.3M | $18.2M | ||
| Q2 24 | $21.6M | $24.0M | ||
| Q1 24 | $-31.5M | $746.0K |
| Q4 25 | 8.6% | 16.0% | ||
| Q3 25 | 20.9% | 13.2% | ||
| Q2 25 | -18.7% | 15.5% | ||
| Q1 25 | 6.0% | 13.9% | ||
| Q4 24 | -2.8% | 16.2% | ||
| Q3 24 | -16.5% | 15.7% | ||
| Q2 24 | 17.0% | 20.1% | ||
| Q1 24 | -28.5% | 0.7% |
| Q4 25 | 0.2% | 3.4% | ||
| Q3 25 | 0.2% | 5.0% | ||
| Q2 25 | 1.6% | 2.9% | ||
| Q1 25 | 0.2% | 2.8% | ||
| Q4 24 | 0.2% | 6.1% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 0.9% | 2.7% | ||
| Q1 24 | 1.6% | 3.0% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 17.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | 2.04× | ||
| Q2 24 | — | 2.89× | ||
| Q1 24 | — | 0.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
